ICH E6(R3) - Good Clinical Practice
ICH E6 IRB/IEC + Informed Consent

ICH E6(R3) - Good Clinical Practice ICH-E6-IRB-IEC-EthicsCommittee-InformedConsent-Vulnerable: ICH E6 Section 3 - Institutional Review Board (IRB) + Independent Ethics Committee (IEC) + Informed Consent + Vulnerable Populations

Section 3 establishes Institutional Review Board (IRB) and Independent Ethics Committee (IEC) responsibilities. IRB/IEC composition + qualifications + procedures + meeting documentation + records; protocol review + initial + continuing + amendment review; emergency procedure review; risk-benefit assessment + safeguards + subject protection. Informed Consent process: voluntary + informed + capacity + understanding + documentation + signed; process not document; information sheet content (purpose + procedures + alternatives + risks + benefits + confidentiality + compensation + insurance + contact + voluntariness + withdrawal); witness + impartial witness if subject illiterate; legally authorised representative for minors or incapacitated subjects; re-consent on new information or protocol amendment; ICH E6(R3) emphasises participant-centric communication + plain language + electronic consent (eConsent) per Annex 2 considerations + multimedia + comprehension verification. Vulnerable populations: minors + pregnant + cognitively impaired + prisoners + employees + students + economically disadvantaged + military personnel + critically ill + indigenous; specific procedural safeguards + assent + parental permission + ombudsperson + extra IRB review; Declaration of Helsinki 2024 alignment; FDA 21 CFR Part 50 (Informed Consent) + Part 56 (IRBs) + Part 50.50-Subpart D (Children) + Part 21 CFR Subpart C (Pregnant) + EU CTR 536/2014. Continuing review at least annually + safety event triggers. Coordinates with FDA + EMA + PMDA + national ethics committees + WHO + WMA Declaration of Helsinki + CIOMS International Ethical Guidelines + Belmont Report. ICH E6 + IRB/IEC + Informed Consent + Vulnerable applies.

What else in your programme already covers this

This control maps to 4 controls across 1 other frameworks. If you already hold one of them, the evidence you collected for it is the starting point here rather than new work.

  • CTR-Art.41_42 Adverse-event and SUSAR reporting (Articles 41-42)
  • CTR-Art.43 Annual safety reporting (Article 43)
  • CTR-Art.47 Compliance with the protocol and Good Clinical Practice (Article 47)
  • CTR-Art.48 Monitoring (Article 48)

Every mapping shown was judged rather than inferred from wording similarity, and the ones that failed review are published too. See the coverage reports and what was rejected.

Query this from an agent

The graph holds this control, the 4 it maps to, and the evidence behind each claim, over MCP and REST.